Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
Heartbeam Inc
NASDAQ BEAT
Data sourced from
and
and
Heartbeam Inc Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2024: USD 0.00
Heartbeam Inc Revenue Per Share is USD 0.00 for the Trailing 12 Months (TTM) ending March 31, 2024, a 0.00% change year over year. Revenue per share measures the amount of revenue generated by a company per outstanding share. It is calculated by dividing the revenue by the number of outstanding shares (weighted average). This ratio provides insights into the company's revenue generation on a per-share basis. A higher revenue per share indicates stronger revenue performance and potentially higher value per share for investors.
-
Heartbeam Inc Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 0.00, a 0.00% change year over year.
-
Heartbeam Inc Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 0.00, a -100.00% change year over year.
-
Heartbeam Inc Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 6.93, a 125.78% change year over year.
-
Heartbeam Inc Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2020 was USD 3.07, a 8.13% change year over year.
Don’t Miss A Beat
Looking to stay ahead of the competition and stay informed? Receive your daily dose of market news, trends, and analysis to kickstart your day and stay up-to-date.
NASDAQ: BEAT
| CEO | Mr. Richard M. Ferrari |
| IPO Date | Nov. 11, 2021 |
| Location | United States |
| Headquarters | 2118 Walsh Avenue, Santa Clara, CA, United States, 95050 |
| Employees | 15 |
| Sector | Healthcare |
| Industry | Health information services |
Description
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
Key trends
StockViz Staff
September 16, 2024
Any question? Send us an email